Jim Simons Enzo Biochem Inc Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Enzo Biochem Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,435,129 shares of ENZ stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,435,129
Previous 2,479,195
1.78%
Holding current value
$2.65 Million
Previous $3.45 Million
10.24%
% of portfolio
0.0%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding ENZ
# of Institutions
45Shares Held
16.6MCall Options Held
0Put Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$5.64 Million4.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$2.05 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.62 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$1.45 Million9.62% of portfolio
-
Tang Capital Management LLC San Diego, CA1.26MShares$1.37 Million0.19% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $53.1M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...